Evidence map›Paper›PMID 31707784›Full record

ArticleBiological research for nursing2020

Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors.

Ashley Henneghan, Andreana P Haley, Shelli Kesler

Open access · greenAbstract read
In one paragraph

Article in Biological research for nursing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Cancer treatment-related cognitive impairment.Neuro-oncology advances · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Distinct sleep disturbance and cognitive dysfunction profiles in oncology outpatients receiving chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ashley HenneghanSchool of Nursing; Department of Oncology, University of Texas at Austin, Austin, TX, USA.ORCID 0000-0002-6733-1926
Andreana P HaleyDepartment of Psychology, College of Liberal Arts, University of Texas at Austin, Austin, TX, USA.
Shelli KeslerSchool of Nursing; Department of Oncology, University of Texas at Austin, Austin, TX, USA.
The University of Texas at Austin · US

Funding

Assessment and Treatment of Cognitive Deficits in Breast CancerDP2OD004445 · OD · STANFORD UNIVERSITY · PI KESLER, SHELLI R · 2008 to 2008
$2.4M
Biobehavioral Contributors to Cognition in Breast Cancer SurvivorsF31NR015707 · NINR · UNIVERSITY OF TEXAS AT AUSTIN · PI HENNEGHAN, ASHLEY M. · 2016 to 2017
$50k
NIH HHS DP2 OD004445NINR NIH HHS F31 NR015707
6 · The paper itself

Abstract

objectiveAccelerated brain aging has been proposed to explain cancer-related cognitive impairment, but empirical evidence for this relationship is lacking. The purpose of this study was to evaluate amyloid beta (Aβ) and tau, biomarkers of neurodegeneration, in relation to cognition in breast cancer survivors (BCSs). We explored relationships among peripheral concentrations of Aβ42, Aβ-40, tau, and cytokines; cognitive function; and psychosomatic symptoms in a cohort of BCSs post-chemotherapy.

methodsThis secondary analysis of a cross-sectional study was conducted with 65 BCSs. Serum total Aβ-42, Aβ-40, and tau levels were measured with single molecule array technology. Cytokines (interleukin [IL]-6, tumor necrosis factor [TNF]-α, granulocyte-macrophage colony-stimulating factor [GM-CSF], interferon [IFN]-g, IL-10, IL-12, IL-13, IL1-b, IL-2, IL-4, IL-5, IL-7, and IL-8) were simultaneously measured in serum using multiplex assays. Cognitive function was measured with five standardized neuropsychological tests and psychosomatic symptoms (stress, loneliness, anxiety, depressive symptoms, fatigue, sleep quality, and daytime sleepiness) with self-report questionnaires. Data analyses included correlations and random forest regression (RFR).

resultsSignificant correlations were identified among hip-to-waste ratio, number of treatment modalities, Aβ-42, Aβ-40, and tau levels (

conclusionsThis study suggests that neurodegenerative biomarkers interact with cytokines to influence cognitive functioning and psychosomatic symptoms in BCSs following chemotherapy, but additional research is needed.

Indexed as

AdultAgedAmyloid beta-PeptidesAntineoplastic AgentsBiomarkersBreast NeoplasmsCancer SurvivorsCognitionCognitive DysfunctionCohort StudiesCross-Sectional StudiesCytokinesFemaleHumansMiddle Agedtau ProteinsAmyloid beta-PeptidesAntineoplastic AgentsBiomarkersCytokinestau Proteinsamyloid betabreast cancer survivorscancer-related cognitive impairmentcytokinespsychosomatic symptomstau

Identifiers

PMID31707784
PMCPMC7068749
OpenAlexW2983789999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.